Global Duchenne Muscular Dystrophy (DMD) Market Emerging Trends, Segment Analysis and Industry Forecast 2022 - 2030

The Global Duchenne Muscular Dystrophy (DMD) Market Report studies extensive evaluation of the market growth predictions and restrictions. The strategies range from new product launches, expansions, agreements, joint ventures, partnerships, to acquisitions. This report comprises of a deep knowledge and information on what the market's definition, classifications, applications, and engagements and also explains the drivers and restraints of the market which is derived from SWOT analysis. Global market analysis report helps a lot for the business and gives solutions to the toughest business questions. The research and analysis have been carried out with one step or the combination of several steps depending upon the business and client necessities.

In terms of revenue, global duchenne muscular dystrophy (DMD) market was valued at US$ 1301.44 Mn in 2021 growing at a CAGR of 4.7% over the forecast period (2022 - 2030).

Get PDF sample report with related graphs & charts (Pre & post COVID-19 impact analysis): https://www.absolutemarketsinsights.com/request_sample.php?id=1385

Duchenne muscular dystrophy (DMD) happens to be a genetic disorder that has been characterized through a progressive muscle degeneration and weakness owing to the alterations of a bodily protein known as dystrophin that aids in keeping muscle cells intact. Duchenne muscular dystrophy (DMD) happens to be one of four conditions called dystrophinopathies. Apart from this, the remaining three diseases part of this group are Becker Muscular dystrophy (BMD, which happens to be a mild form of DMD); which is an intermediate clinical presentation among the Duchenne muscular dystrophy and Becker Muscular dystrophy; along with the DMD-linked dilated cardiomyopathy, a heart-disease with very less clinical skeletal, or even voluntary, muscle dystrophy. The symptoms of this diseases are likely to be seen majorly in early childhood, generally in the ages 2 and 3. The DMD mainly affects boys, though the girls can also witness the symptoms of this disease.

This disease was first described by a neurologist originating from the country of France named Guillaume Benjamin Amand Duchenne in the years between 1860 and 1870, though even hundred years after this, very little was known about what causes this disease. Later in the year 1986, the identification of a particular gene on the X chromosome was done by couple of researchers. This gene, when gets affected or mutated turns into or causes DMD. In the next year, the protein linked with this gene was identified and was named as dystrophin. Lower levels of the dystrophin protein in muscle cells makes them fragile and can be damaged easily. One of the major symptoms of DMD is the muscle weakness. This dystrophy starts from the age of 2 or 3, initially affecting the muscles that are important for the body and later gets better of the distal limb muscles. Normally, the external muscles placed in the lower part of the body are affected before the upper ones. The kid affected with the disorder is likely to have difficulty in various activities like walking, running and jumping. On the other hand, other symptoms are inclusive of enlarged calves, along with waddling gait, and lumbar lordosis which is an inward curve of the spine. Ultimately the disorder also gets better of the heart and respiratory muscles affecting them. Rising prevalence of this disorder in the children across various nation is the reason why the global duchenne muscular dystrophy (DMD) market is growing aggressively.

Speak to our analyst in case of queries before buying this report: https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=1385

Some of the Key Players Operating in the Global Duchenne Muscular Dystrophy (DMD) Market include: 
Antisense Therapeutics Limited
Capricor Therapeutics.
Dyne Therapeutics
Edgewise Therapeutics
Entrada Therapeutics, Inc
FibroGen, Inc.
PepGen Inc.
Pfizer Inc.
Sarepta Therapeutics, Inc.
Solid Biosciences Inc
Taiho Pharmaceuticals Co. Ltd
Wave Life Sciences
Other Industry Participants

Ask for discount on this report: https://www.absolutemarketsinsights.com/ask_for_discount.php?id=1385

Key Insights of the Report:
The report provides key statistics on the market status of the Duchenne Muscular Dystrophy (DMD) manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
The report presents the company profile, product specifications, capacity, production value, and 2022-2030 market shares for key vendors.
The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
The report estimates 2022-2030 market development trends of Duchenne Muscular Dystrophy (DMD) industry.
Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out
The report makes some important proposals for a new project of Duchenne Muscular Dystrophy (DMD) Industry before evaluating its feasibility.

Purchase the latest in-depth Global Duchenne Muscular Dystrophy (DMD) Market Report @ https://www.absolutemarketsinsights.com/checkout?id=1385

Global Duchenne Muscular Dystrophy (DMD) Market Segmentation:

By Diagnosis
Enzyme Tests
Blood test
Genetic Testing
Muscle biopsy
CT Scan
Electromyogram (EMG)
Electrocardiogram (ECG or EKG)
Others

By Stages
Early Ambulatory
Late Ambulatory
Early Non-Ambulatory
Late Non-Ambulatory

By Clinical Phase
Pre-clinical
Phase 1
Phase 2
Phase 3
Phase 4
Approval

By Age Group
1 to 4 years
5 to 7 years
8 to 11 years
12 to 19 years
Adults

By Treatment
Medication
Therapy
Surgery
Diet and Nutritional supplements
Others

By Geography
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of the Middle East and Africa]

Request for customization to meet your precise research requirements: https://www.absolutemarketsinsights.com/request_for_customization.php?id=1385

We appreciate your reading the article in its entirety. If you would like to know more about the Duchenne Muscular Dystrophy (DMD) market, looking for customization, contact us. To achieve a full market reach of Duchenne Muscular Dystrophy (DMD), or explore more about opportunities reach our research analyst. Our team is available 24/7 to assist and support our customers through reliable research.

View our exclusive press releases on Industry Global News24 - https://industryglobalnews24.com

Contact Us:
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91-7400-24-24-24, US +1-510-420-1213
Website: www.absolutemarketsinsights.com

About Us:
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.

This release was published on openPR.